The Safety of Anaesthetising Biochemically Hyperthyroid Patients Undergoing Thyroidectomy—A Retrospective Cohort Study
Authors:
- 1 July 2018
- journal article
- research article
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 46 (4) , 396-399
Abstract
Traditionally it is recommended that hyperthyroid patients should be made euthyroid prior to thyroidectomy. However, several small observational studies have reported no increase in adverse events when hyperthyroid patients undergo thyroidectomy. The aim of this study was to assess outcomes following total thyroidectomy in patients who were biochemically hyperthyroid at the time of surgery compared to those who were euthyroid. One hundred and fifty-one eligible patients undergoing thyroidectomy for hyperthyroidism between January 2012 and February 2016 were identified, of whom 57 were hyperthyroid on perioperative blood tests and 94 were euthyroid (comparison group). Primary outcomes were 30-day mortality, increased length of postoperative hospital stay and intraoperative signs consistent with thyrotoxicosis (e.g. heart rate >100 per minute, systolic blood pressure >180 or 38°C). Secondary outcomes were intraoperative beta-blocker use and level of care required postoperatively. Thirty-day mortality was zero. The only significant difference between the two groups was a higher use of intraoperative beta-blockers amongst hyperthyroid patients (28.1% versus 8.5%, P=0.002). Our findings suggest that thyroidectomy for mild to moderate biochemical hyperthyroidism performed by an experienced thyroid surgeon and anaesthetist, is associated with increased intraoperative beta-blocker use but no statistical difference in mortality, length of postoperative stay or intraoperative signs consistent with thyrotoxicosis. While we still recommend attempting to achieve a euthyroid state whenever possible prior to thyroid surgery, mild to moderate degrees of residual biochemical hyperthyroidism when appropriately managed may not be associated with an increase in adverse outcomes.Keywords
This publication has 10 references indexed in Scilit:
- Total Thyroidectomy as Primary Definitive Treatment for Graves’ HyperthyroidismThe American Surgeon™, 2013
- Total thyroidectomy for Graves’ disease: Compliance with American Thyroid Association guidelines may not always be necessarySurgery, 2013
- Thyroid cancer in Graves’ disease: is surgery the best treatment for Graves’ disease?Anz Journal of Surgery, 2012
- Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?The Journal of Laryngology & Otology, 2012
- Total Thyroidectomy Is Superior to Subtotal Thyroidectomy for Management of Graves’ Disease in the United StatesWorld Journal of Surgery, 2009
- Perioperative management of the thyrotoxic patientEndocrinology and Metabolism Clinics of North America, 2003
- The Importance of Surgeon Experience for Clinical and Economic Outcomes From ThyroidectomyAnnals of Surgery, 1998
- Thyroid Storm: Potential Perioperative CrisisAORN Journal, 1990
- Graves' DiseaseArchives of internal medicine (1960), 1988
- Propranolol and Thyroidectomy in the Treatment of ThyrotoxicosisAnnals of Surgery, 1982